Dana Graybosh
Analyst
Learring Partners
Equibles does not estimate personal net worth.
About Dana Graybosh
Dana Graybosh is recorded as Analyst at Learring Partners. Dana Graybosh has spoken on 1 investor event across 1 company, most recently for Arcus Biosciences, Inc. on October 20, 2026. The companies whose calls Dana Graybosh spoke on are classified in the Healthcare sector.
Dana Graybosh on recent calls
“I'm wondering if BMS is contributing to funding Peak 20 and whether you allow patients to receive subcutaneous nivolumab, particularly when you go down to the doublet with CAS.”
Affiliation history
-
Learring Partners
Analyst
Transcript header (unverified)
Current